More MS news articles for May 2002

Over 50 Leading Healthcare Organizations to Improve Patient and Physician Awareness of Clinical Trials by Offering the HopeLink Service To Millions of Users Each Month

http://globalarchive.ft.com/globalarchive/article.html?id=020501002972&query=sclerosis

May 1, 2002
PR Newswire - USA

HopeLink Corporation, a privately held healthcare information technology company, today announced that more than 50 organizations, consisting mainly of non-profit patient advocacy groups and some targeted health portals, have joined the HopeLink Syndicated Network of partners. The Network now reaches millions of highly-targeted users per month, and is the primary distribution channel for the groundbreaking HopeLink Clinical Trial Service, a hosted, web-based application that helps increase patient awareness and enrollment in cancer trials by improving access to clinical trial information and enabling organizations that sponsor or conduct clinical trials to streamline components of the process.

"Physicians and healthcare professionals depend on keeping up-to-date with cutting-edge information," said Michael LeNoir, Principal Investigator of the National Medical Association's Project I.M.P.A.C.T. (Increase Minority Participation and Awareness of Clinical Trials.) "By adding the HopeLink Clinical Trial Service to our website, more than 25,000 member physicians will be better equipped to evaluate and direct their patients to treatment options that may be appropriate. We are extremely concerned about improved access to treatment information for African-Americans and other minorities and the HopeLink Clinical Trial Service represents an excellent opportunity to bring physicians and patients together in the decision-making process."

The HopeLink Clinical Trial Service, a free, easy-to-use, comprehensive database of over 1,800 cancer trials, provides patients, advocates, physicians, research professionals and healthcare organizations with the latest information on drug therapies under development, including enrollment information and preliminary eligibility requirements.

"Prostate cancer has a devastating impact on American men and their families and we must equip survivors and advocates with the most useful and effective tools," said Skip Lockwood, Vice-President of the National Prostate Cancer Coalition. "The HopeLink Clinical Trial Service is a tremendous asset as it provides patients and families with cutting edge research and potentially life-saving treatments."

"The Lance Armstrong Foundation is constantly concerned that the more than one million patients who will be diagnosed with cancer this year are aware of all the options available to them," said Doug Ulman, Director of Survivorship of the organization founded by cancer survivor and cycling champion Lance Armstrong. "By offering the HopeLink Clinical Trial Service on our website, we can help expedite the availability of critical and timely information that enables patients to evaluate their choices and determine their treatment path."

"The HopeLink Clinical Trial Service has an incredible patient focus and helps to open up the communication process between patients and doctors," said Karen Towne, Survivorship Program Coordinator, Ovarian Cancer National Alliance. "Clinical trials are so confusing for patients and lead to so much frustration and loss of control. Using HopeLink is a great way to put control back in the hands of patients."

The more than 50 organizations that are presenting the HopeLink Clinical Trial Service on their websites as part of the HopeLink Syndicated Network include: Alliance for Lung Cancer Advocacy, Support and Education (ALCASE); American Foundation for Urologic Disease; American-Italian Cancer Foundation; American Prostate Society; Annie Appleseed Project; CancerGroup.com; Cancer Treatment Research Foundation; Center for Patient Advocacy; Cherubim Foundation; ClinicalTrials.com; Colon Cancer Alliance; Colorectal Cancer Network; Dattoli Cancer Foundation/Prostate Cancer Resource Network; Family to Family; Florida Prostate Cancer Network; Healthcommunities.com's OncologyChannel.com, UrologyChannel.com, and WomensHealthChannel.com; HealthFrontier.com; HealthLinks.net; Hirshberg Foundation For Pancreatic Cancer Research; Intercultural Cancer Council; International Myeloma Foundation; Kidney Cancer Association; Lance Armstrong Foundation; Leukemia Links; Lung Cancer Online; National Brain Tumor Foundation; National Breast Cancer Coalition; National Consortium of Breast Centers; National Medical Association; National Melanoma Foundation; National Multiple Sclerosis Society; National Ovarian Cancer Coalition; National Pancreas Foundation; National Prostate Cancer Coalition; Oncology Nursing Society; Ovarian Cancer National Alliance; Pancreas.org; Patient-Centered Guides; Prostate Help-Patients Helping Patients; SHARE; SusanLoveMD.com; The Breast Cancer Fund; The Damon Harris Cancer Foundation; The Leukemia & Lymphoma Society; The Lustgarten Foundation for Pancreatic Cancer Research; The Prostate Net; The William S. Graham Foundation for Melanoma Research; TheBreastCareSite.com; Us Too! International; and Walter Payton Cancer Fund. In addition, the service is accessible through listings on websites such as CancerLinks, Pancreatic Cancer Action Network, TrialsCentral and other leading health services.

"The reception the HopeLink Clinical Trial Service has received from our partners, as well as their constituents, has been tremendous," states Jim Messemer, President & CEO of HopeLink. "As more entities become interested in providing permission-based health solutions, we are committed to providing the tools and services that are necessary to improving healthcare research and information exchanges."

"I see the HopeLink menu up more and more on the screens of information specialists in our Information & Resource Center," said Hildy Dillon, National Senior Director, Information Resource Center, of The Leukemia & Lymphoma Society. "We are able to walk patients and their advocates through the HopeLink service on our website, enabling them to find clinical trial information and keep abreast of the newest treatment options available."

"Given the inherent promise in its name, HopeLink has a lot to live up to," states Mike Katz, a board member of the International Myeloma Foundation. "They have risen to the challenge by building a powerful, consumer-friendly service designed to help patients and caregivers find out about clinical trials that can help them today and give them hope for tomorrow. It is one of the more heavily used links on our myeloma.org website and we get very positive comments from our constituents. HopeLink is clearly making a difference!"

Organizations interested in presenting the HopeLink Clinical Trial Service on their websites and becoming a Syndicated Network partner, or clinical trial sponsors interested in listing trials on the service can email info@hopelink.com.

About HopeLink

HopeLink is a privately held healthcare information technology company that provides products and services that build efficiency into the clinical trial process by enabling information access between drug developers, patients, and their respective agents. The company's initial product improves access to trial information and accelerates patient enrollment into trials. The HopeLink Clinical Trial Service, a comprehensive hosted database of cancer trial listings, is widely available at the websites of HopeLink's Syndicated Network partners. Additional information on HopeLink is available at http://www.hopelink.com/.

Contact: Mani Dhanoa of HopeLink Corporation, +1-650-373-7300, ext. 220
 

All Material Subject to Copyright